Search clinical trials for: Zolpidem CR

Total 463 results

M.D. Anderson Cancer Center
Bristol-Myers Squibb

Terminated

Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)

Leukemia

United States
Pfizer

Completed

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

Chronic Pain | Analgesia | Opioid-related Disorders | Narcotic Abuse
Nutrition 21, Inc.

Completed

Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM

Diabetes Mellitus, Type 2
Walter Reed Army Institute of Research (WRAIR)

Enrolling by invitation

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Performance Enhancing Product Use

United States
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal

Sleep Disorder | Traditional Chinese Medicine

China
Janssen Research & Development, LLC

Completed

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Healthy Non-dependent, Recreational Sedative Users | Abuse Potential

United States
GlaxoSmithKline

Completed

Disturbed Sleep Model Study.

Sleep Initiation and Maintenance Disorders

United Kingdom
Hamilton Health Sciences Corporation
National Health and Medical Research Council, Australia; Canadian Institutes... and other collaborators

Terminated

POISE Trial: Perioperative Ischemic Evaluation Study (POISE)

Cardiovascular Diseases

Canada
McGill University Health Centre/Research Institute...
Weston Brain Institute

Completed

Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

Parkinson's Disease | Obstructive Sleep Apnea

Canada
Lupin Ltd.

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions

Pharmacokinetic Study

India
Nutrition 21, Inc.

Completed

A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM

Diabetes Mellitus, Type 2

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) (Orion)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, France, Poland, Russian Federation, Romania, Ukraine, Germany, Hungary, Slovakia, Serbia, Canada
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder

Insomnia Disorders

Belgium, United States, Germany, Poland, Japan, France
M.D. Anderson Cancer Center
Seagen Inc.

Terminated

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)

Leukemia

United States
SK Chemicals Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Ischemic Stroke

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Completed

Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) (AcSDKP-NH2)

Healthy | Chronic Kidney Disease

France
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Insomnia Disorder

United States, Germany, Spain, Hungary, Israel, Sweden
Hadine Joffe, MD
National Institute of Mental Health (NIMH)

Completed

Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

Depression | Sleep Initiation and Maintenance Disorders

United States
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain

Low Back Pain
Samsung Medical Center

Completed

Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder

Panic Disorder

Korea, Republic of
GlaxoSmithKline

Completed

Depression Study In Elderly Patients

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Pain | Lower Back Pain | Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Canada
University of Oklahoma
GlaxoSmithKline

Completed

Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease

Coronary Artery Disease

United States
Inje University
GlaxoSmithKline

Unknown

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

Panic Disorder

Korea, Republic of
University of Calgary
Ferring Pharmaceuticals

Not yet recruiting

Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis

Microscopic Colitis
M.D. Anderson Cancer Center
Celgene

Completed

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Leukemia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
GlaxoSmithKline

Completed

Major Depressive Disorder Study In Adults

Major Depressive Disorder

United States
Massachusetts General Hospital

Completed

Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy

Stress Disorders, Post-Traumatic

United States
GlaxoSmithKline

Completed

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Depressive Disorder, Major | Major Depressive Disorder (MDD)

China
GlaxoSmithKline

Completed

PAXIL CR Bioequivalence Study

Depressive Disorder

United States
Duke University
GlaxoSmithKline

Completed

Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

United States
NLS Pharmaceutics

Not yet recruiting

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 (AMAZE)

Narcolepsy Type 1 | Narcolepsy With Cataplexy
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

Leukemia

United States
Oslo University Hospital
Helse More and Romsdal Trust

Active, not recruiting

Kinematics of Contemporary Knee Arthroplasty

Knee Osteoarthritis

Norway
Viatris Korea

Recruiting

Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets

Peripheral Neuropathic Pain

Korea, Republic of
GlaxoSmithKline

Completed

Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
Duke University
Massachusetts General Hospital; GlaxoSmithKline

Completed

Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy

Stress Disorders, Post-Traumatic

United States
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Completed

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease (AD-Combi)

Alzheimer's Disease
Massachusetts General Hospital
National Institutes of Health (NIH)

Completed

Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep

Insomnia

United States
University of California, Los Angeles

Completed

18-Month Study of Memory Effects of Curcumin (Curcumin)

Mild Cognitive Impairment (MCI) | Age-associated Cognitive Impairment

United States
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Azacytidine and Valproic Acid in Patients With Advanced Cancers

Advanced Cancers

United States
Medical University of South Carolina
GlaxoSmithKline

Completed

Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence

PTSD

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Czech Republic, Poland, Hungary, Belgium, Germany
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer

Solid Tumors

United States
Research Foundation for Mental Hygiene, Inc.
National Institute of Mental Health (NIMH)

Completed

Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack

Posttraumatic Stress Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease

Arthritis | Joint Diseases | Osteoarthritis
GlaxoSmithKline

Withdrawn

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Depressive Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Terminated

A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)

Diabetic Neuropathy, Painful | Diabetic Polyneuropathy

United States
Jack Edinger, PhD
National Institute of Mental Health (NIMH); National Institutes of Health (NIH)

Completed

Sequenced Therapies for Comorbid and Primary Insomnias

Primary Insomnia | Insomnia Comorbid to Psychiatric Disorder

United States, Canada

Search clinical trials for: Zolpidem CR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations